Biology Decoded

biologydecoded.com

We are young entrepreneurs who were previously operating only an online magazine titled “Biology Decoded”. We are now launching printable version of Biology Decoded scheduled to be out by May 2016. We are mainly targeting the students and the faculty members of COMSATS Biosciences Department, in Islamabad, with our first issue. We plan to spread our magazine across Pakistan with subsequent issues. The goal of the Biology Decoded is to become a high impact factor biology journal of Pakistan and publishing our first issue of Biology Decoded magazine is the initial step towards our goal. As being the students of Biosciences we saw lack of awareness and opportunities for the students of biosciences in Pakistan, thus we aim to change the perspective of the students towards this field so they can contribute towards the development and application of this field in Pakistan. This magazine is student focused and is written in a non-technical manner so that everyone can benefit from it.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

FRED HUTCH MANDATES REMOTE WORKING TO CURB COVID-19

FierceBiotech | March 06, 2020

news image

The Fred Hutchinson Cancer Research Center is making its Seattle-based staff work from home in light of the emergence of a cluster of coronavirus cases in the city. The precautionary action comes as biopharma companies are starting to pull back from face-to-face events to cut the risk of their employees catching the virus. As of Thursday, all of Fred Hutch’s Seattle-based employees, bar security and other staff that need to be on campus, are working remotely. Fred Hutch plans to keep the m...

Read More

MEDICAL

THERMO FISHER SCIENTIFIC AND QATAR GENOME PROGRAM PARTNER TO ADVANCE PRECISION MEDICINE

Thermo Fisher Scientific | May 24, 2022

news image

Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally. Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom* custom genotyping array for pan-Arab populations using w...

Read More

CELL AND GENE THERAPY

2SEVENTY BIO ANNOUNCES EXPANDED COLLABORATION AGREEMENT WITH NOVO NORDISK TO CONTINUE DEVELOPMENT OF IN VIVO GENE EDITING APPROACH

2seventy bio, Inc | January 07, 2022

news image

2seventy bio, Inc. announced that it has entered into an option and license agreement with Novo Nordisk for joint research and development of an in vivo gene editing treatment for hemophilia A. This agreement builds upon a successful existing multi-year research collaboration between the two companies. Under the terms of this agreement, Novo Nordisk will have the option to license 2seventy bio’s proprietary mRNA-based megaTAL™ technology for the development of a new treatment approac...

Read More

TWINSTRAND BIOSCIENCES LAUNCHES DUPLEX SEQUENCING TECHNOLOGY

BioSpace | February 25, 2020

news image

TwinStrand Biosciences™, a next-generation DNA sequencing technology company, today announced the launch of TwinStrand Duplex Sequencing™ Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco Island, Florida. At launch, the company will offer their platform technology for two research applications: detection of minimal residual disease in acute myeloid leukemia patients (AML MRD) and a multi-species genetic toxicology assay for rapid ...

Read More
news image

FRED HUTCH MANDATES REMOTE WORKING TO CURB COVID-19

FierceBiotech | March 06, 2020

The Fred Hutchinson Cancer Research Center is making its Seattle-based staff work from home in light of the emergence of a cluster of coronavirus cases in the city. The precautionary action comes as biopharma companies are starting to pull back from face-to-face events to cut the risk of their employees catching the virus. As of Thursday, all of Fred Hutch’s Seattle-based employees, bar security and other staff that need to be on campus, are working remotely. Fred Hutch plans to keep the m...

Read More
news image

MEDICAL

THERMO FISHER SCIENTIFIC AND QATAR GENOME PROGRAM PARTNER TO ADVANCE PRECISION MEDICINE

Thermo Fisher Scientific | May 24, 2022

Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally. Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom* custom genotyping array for pan-Arab populations using w...

Read More
news image

CELL AND GENE THERAPY

2SEVENTY BIO ANNOUNCES EXPANDED COLLABORATION AGREEMENT WITH NOVO NORDISK TO CONTINUE DEVELOPMENT OF IN VIVO GENE EDITING APPROACH

2seventy bio, Inc | January 07, 2022

2seventy bio, Inc. announced that it has entered into an option and license agreement with Novo Nordisk for joint research and development of an in vivo gene editing treatment for hemophilia A. This agreement builds upon a successful existing multi-year research collaboration between the two companies. Under the terms of this agreement, Novo Nordisk will have the option to license 2seventy bio’s proprietary mRNA-based megaTAL™ technology for the development of a new treatment approac...

Read More
news image

TWINSTRAND BIOSCIENCES LAUNCHES DUPLEX SEQUENCING TECHNOLOGY

BioSpace | February 25, 2020

TwinStrand Biosciences™, a next-generation DNA sequencing technology company, today announced the launch of TwinStrand Duplex Sequencing™ Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco Island, Florida. At launch, the company will offer their platform technology for two research applications: detection of minimal residual disease in acute myeloid leukemia patients (AML MRD) and a multi-species genetic toxicology assay for rapid ...

Read More